The evidence that somatic mutations or the copy-number loss of TP53 were accumulated in Cluster 3 (Fig. 3a) could support the histological diagnosis and suggests the necessity of the disruption of the MDM2-TP53 axis during the development of DDLPS. Here, TP53 is linked to dedifferentiated liposarcoma.